language:
Find link is a tool written by Edward Betts.searching for Bevacizumab 61 found (516 total)
alternate case: bevacizumab
Rubeosis iridis
(409 words)
[view diff]
exact match in snippet
view article
find links to article
Mouser JG, Derick RJ. "Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection." Retina. 2006 Mar;26(3):354-6. PMID 16508439.Choroid plexus papilloma (2,294 words) [view diff] exact match in snippet view article find links to article
with leptomeningeal dissemination require adjuvant treatment as well. Bevacizumab is playing a bigger part in disseminated choroid plexus papilloma, accordingEvofosfamide (3,706 words) [view diff] exact match in snippet view article find links to article
Investigational Hypoxia-Targeted Drug, TH-302, and Bevacizumab in Recurrent Glioblastoma Following Bevacizumab Failure. Brenner, et al. 2014 ASCO, 7 – 30 MayRoy S. Herbst (1,334 words) [view diff] exact match in snippet view article find links to article
evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosineFosbretabulin (342 words) [view diff] exact match in snippet view article find links to article
Combination of Carboplatin, Paclitaxel, and Bevacizumab ± Combretastatin A4 Phosphate (CA4P) Followed by Bevacizumab ± CA4P in Subjects With Chemotherapy NaïveCUSP9 (883 words) [view diff] exact match in snippet view article find links to article
cocktail, (ClinicalTrials.gov Identifier: NCT01356290)- non-cytotoxic drugs bevacizumab, thalidomide, celecoxib, and fenofibric acid to augment traditional cytotoxicPrimary peritoneal carcinoma (503 words) [view diff] exact match in snippet view article find links to article
Benjamin E.; Sorosky, Joel I. (20 November 2007). "Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary PeritonealRetinal haemorrhage (1,042 words) [view diff] exact match in snippet view article find links to article
LARetinaSurgeon.com. Spaide RF, Fisher YL (March 2006). "Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicatedBradley J. Monk (3,280 words) [view diff] exact match in snippet view article find links to article
treatment for persistent, metastatic and recurrent cervical cancer adding bevacizumab to existing options. In addition to chemotherapy added to radiation,Irinotecan (2,315 words) [view diff] exact match in snippet view article find links to article
the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab". Chinese Journal of Cancer. 35 (1): 102. doi:10Abemaciclib (1,434 words) [view diff] exact match in snippet view article find links to article
(AflacST1501)". www.clinicaltrials.gov. Retrieved 20 July 2023. "Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6"Bridget Robinson (393 words) [view diff] exact match in snippet view article find links to article
trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patientsBhuvaneswari Ramaswamy (596 words) [view diff] exact match in snippet view article find links to article
She later participated in a clinical trial which treated patients with bevacizumab, before it was revoked by the Food and Drug Administration for its potentialBhuvaneswari Ramaswamy (596 words) [view diff] exact match in snippet view article find links to article
She later participated in a clinical trial which treated patients with bevacizumab, before it was revoked by the Food and Drug Administration for its potentialPSivida (208 words) [view diff] exact match in snippet view article find links to article
Dinesh K. Nadarassan presented a poster entitled "Sustained Release of Bevacizumab (Avastin) from BioSilicon" pSivida Mesoporous silicon patent v t e vIFL (chemotherapy) (109 words) [view diff] exact match in snippet view article
Zhang, Q; Shen, Y; Zhou, T (2016). "Efficacy and safety of addition of bevacizumab to FOLFIRI or irinotecan/bolus 5-FU/LV (IFL) in patients with metastaticPresumed ocular histoplasmosis syndrome (534 words) [view diff] exact match in snippet view article find links to article
June 2010. Ehrlich R, Ciulla TA, Maturi R, et al. (2009). "Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosisSTAT6 (2,077 words) [view diff] exact match in snippet view article find links to article
Sarkar S (June 2005). "Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastaticG1 Therapeutics (2,065 words) [view diff] exact match in snippet view article find links to article
Trial of Trilaciclib Versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer". {{cite journal}}: Cite journal requiresTIGIT (1,985 words) [view diff] exact match in snippet view article find links to article
carcinoma setting. In the MORPHEUS-liver trial, tiragolumab + atezolizumab + bevacizumab significantly improved response rate and PFS in both patients with positiveTower Cancer Research Foundation (1,133 words) [view diff] exact match in snippet view article find links to article
12, pp. 4569–4572. A Phase Ib Study of AMG 102 in Combination with Bevacizumab or Motesanib in Patients with Advanced Solid Tumors- Clinical CancerSelective internal radiation therapy (4,492 words) [view diff] exact match in snippet view article find links to article
Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in PatientsNational Eye Institute (5,698 words) [view diff] exact match in snippet view article find links to article
Grunwald, J. E.; Fine, S. L.; Jaffe, G. J. (2011-05-19). "Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration". New England JournalARMS2 (688 words) [view diff] exact match in snippet view article find links to article
response of exudative age-related macular degeneration to intravitreal bevacizumab". Ophthalmology. 114 (12): 2168–73. doi:10.1016/j.ophtha.2007.09.008Vatalanib (564 words) [view diff] exact match in snippet view article find links to article
EE (April 2007). "Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer". The OncologistChoroid plexus tumor (1,786 words) [view diff] exact match in snippet view article find links to article
Saikali, Atypical choroid plexus papilloma treated with single agent bevacizumab, Rare Tumors 6 (1) (2014)33–35 A. Passariello, M. Tufano, P. SpennatoSickle cell retinopathy (2,209 words) [view diff] exact match in snippet view article find links to article
associated with sea fan lesions which are types of neovascularization. Bevacizumab is an anti-VEGF drug used in intravitreal injection that is known toDiabetic papillopathy (552 words) [view diff] exact match in snippet view article find links to article
"Diabetic papillopathy with macular edema treated with intravitreal bevacizumab". Oman Journal of Ophthalmology. 4 (3): 135–138. doi:10.4103/0974-620XChoroid plexus tumor (1,786 words) [view diff] exact match in snippet view article find links to article
Saikali, Atypical choroid plexus papilloma treated with single agent bevacizumab, Rare Tumors 6 (1) (2014)33–35 A. Passariello, M. Tufano, P. SpennatoNeprilysin (2,697 words) [view diff] exact match in snippet view article find links to article
E, Sarkar S (2005). "Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastaticRadiation retinopathy (407 words) [view diff] exact match in snippet view article find links to article
PMID 15923510. Finger, PT; Mukkamala, SK (Jul–Aug 2011). "Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy". EuropeanAtul Kumar (ophthalmologist) (1,391 words) [view diff] exact match in snippet view article
PMID 28345560. Kumar, Atul; Ravani, Raghav (July 2017). "Using intravitreal bevacizumab (Avastin®) – Indian Scenario". Indian Journal of Ophthalmology. 65 (7):HOHMS (999 words) [view diff] exact match in snippet view article find links to article
cell carcinoma (cisplatinum/gemcitabine) Squamous cell carcinoma (no bevacizumab/anti-VEGF in cavitary or in near large vessels Vincent MD (August 2009)NAB2 (850 words) [view diff] exact match in snippet view article find links to article
E; Sarkar, S (2005). "Combined analysis of efficacy: The addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastaticChemotherapy regimen (562 words) [view diff] exact match in snippet view article find links to article
a [possibly critical and not peer reviewed] comment to Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. Cancer.net - ExplainingTecemotide (1,700 words) [view diff] exact match in snippet view article find links to article
(L-BLP25) Phase 2 124 Merck KGaA NCT00828009 BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With NewlyJames A. Wells (2,036 words) [view diff] exact match in snippet view article find links to article
hormone antagonist for treatment of acromegaly, humanization of the Bevacizumab (Avastin) a VEGF antagonist for treating cancers, and engineered proteasesJames A. Wells (2,036 words) [view diff] exact match in snippet view article find links to article
hormone antagonist for treatment of acromegaly, humanization of the Bevacizumab (Avastin) a VEGF antagonist for treating cancers, and engineered proteasesNancy Y. Lee (707 words) [view diff] exact match in snippet view article find links to article
J, Hu K, Le QT, Colevas AD, Glisson BS, Chan AT, Ang KK. Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngealTina Young Poussaint (778 words) [view diff] exact match in snippet view article find links to article
; Boyett, James M.; Kun, Larry E. (2010-06-20). "Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and DiffusePartition coefficient (6,379 words) [view diff] exact match in snippet view article find links to article
Gaweł; Kwapiszewska, Karina; Hołyst, Robert (2023). "Cellular Uptake of Bevacizumab in Cervical and Breast Cancer Cells Revealed by Single-Molecule Spectroscopy"Hedgehog signaling pathway (6,895 words) [view diff] exact match in snippet view article find links to article
GDC-0449 (Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer" at ClinicalTrialsAdegramotide (125 words) [view diff] exact match in snippet view article find links to article
May 2017). "A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following InitialMesothelioma (10,694 words) [view diff] exact match in snippet view article find links to article
emerged to help slow the growth of oncogenic abnormalities. For example, bevacizumab, a humanized monoclonal antibody, is directed at the vascular endothelialGholam A. Peyman (2,006 words) [view diff] exact match in snippet view article find links to article
loss from retinitis pigmentosa (2004) Testing intravitreal toxicity of Bevacizumab (Avastin), (2006) Oscillatory photodynamic therapy for choroidal neovascularizationGoldmann–Favre syndrome (1,273 words) [view diff] exact match in snippet view article find links to article
can be used. Treatment methods such as 810 nm diode laser ablation, bevacizumab and/or triamcinolone acetonide provided control to some of the ocularFine chemical (12,113 words) [view diff] exact match in snippet view article find links to article
Prolia denosumab Amgen 4 Rituxan rituximab Roche/Biogen Idec 5 Avastatin bevacizumab Roche 6 Herceptin trastuzumab Roche 7 Remicade infliximab J&J/Merck &Targeted drug delivery (4,427 words) [view diff] exact match in snippet view article find links to article
Reimann, JD; Vassel, A (2003). "A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer". Seminars in OncologyEric Winer (985 words) [view diff] exact match in snippet view article find links to article
Berry DA, Perou CM, et al. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense DoxorubicinMedical ultrasound (13,632 words) [view diff] exact match in snippet view article find links to article
"Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—PreliminaryDiffuse neonatal hemangiomatosis (4,379 words) [view diff] exact match in snippet view article find links to article
vinscritine, thalidomide, temozolimide, propranolol, interferon, and bevacizumab can be used to combat intracranial hemangioma. Propranolol is the mostDendritic cell-based cancer vaccine (1,616 words) [view diff] exact match in snippet view article find links to article
prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitiveDenifanstat (310 words) [view diff] exact match in snippet view article find links to article
(5 July 2023). "Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma". Clinical CancerBeth Overmoyer (737 words) [view diff] exact match in snippet view article find links to article
February 2005). "Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breastSUCNR1 (9,204 words) [view diff] exact match in snippet view article find links to article
DE, Soeharto DA (December 2022). "One year follow-up of intravitreal bevacizumab injection in Aggressive Retinopathy of Prematurity at Indonesian nationalOsteopontin (8,315 words) [view diff] exact match in snippet view article find links to article
an in vivo study and also when hybridized with the anti-VEGF antibody bevacizumab . At least one clinical trial is exploring the use of osteopontin asChristodoulos I. Stefanadis (1,427 words) [view diff] exact match in snippet view article find links to article
heating of stented arterial segments, and evolution and application of bevacizumab-eluting stent for the inhibition of microvessel growth in unstable atheroscleroticWafik El-Deiry (3,588 words) [view diff] exact match in snippet view article find links to article
postoperatively increases colon cancer recurrence risk". "No Survival Benefit with Bevacizumab Maintenance in CRC". "Scientific Founder, Oncoceutics". An interviewNicholas J. Vogelzang (2,616 words) [view diff] exact match in snippet view article find links to article
Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients with Malignant Mesothelioma". Journal of ClinicalElisa Rush Port (1,686 words) [view diff] exact match in snippet view article find links to article
Hudis, Eric P. Winer. "Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel followed by dose-dense doxorubicin andOvarian squamous cell carcinoma (3,069 words) [view diff] exact match in snippet view article find links to article
combining chemotherapy with the humanized anti-VEGF monoclonal antibody, bevacizumab, in the treatment of recurrent, persistent, or metastatic cervical cancer